Company · CIK 0001645569
DICE Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 30
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/ADICE Therapeutics, Inc.0001104659-23-089350 · 85.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-206894 · 295.7 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-23-039758 · 6.5 MBSEC(opens sec.gov)
- SC 13G/ADICE Therapeutics, Inc.0000315066-23-002366 · 8.5 KBSEC(opens sec.gov)
- SC 13D/ADICE Therapeutics, Inc.0001193125-23-173955 · 96.4 KBSEC(opens sec.gov)
- SC 13D/ADICE Therapeutics, Inc.0001193125-23-172591 · 107.8 KBSEC(opens sec.gov)
- SC 13D/ADICE Therapeutics, Inc.0001104659-23-073390 · 92.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-169553 · 957.3 KBSEC(opens sec.gov)
- 8-KCurrent report0000950170-23-026821 · 286.5 KBSEC(opens sec.gov)
- 8-KCurrent report0000950170-23-021228 · 317.4 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
400 EAST JAMIE COURT SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
mailing
400 EAST JAMIE COURT SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
Former names
- DiCE Molecules Holdings, LLC2021-09-10
- DiCE MOLECULES HOLDINGS, LLC2021-09-10
Same industry